The role of the pharmacist in the care of patients with colorectal cancer

被引:0
作者
Le Vu, Dominique [1 ]
机构
[1] 13 Lieu Dit Bodeno, F-56400 Plougoumelen, France
来源
ACTUALITES PHARMACEUTIQUES | 2023年 / 62卷 / 625期
关键词
care pathway; colorectal cancer; diagnosis; pharmacist; screening; therapeutic protocol;
D O I
10.1016/j.actpha.2023.02.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The role of the pharmacist in the care of patients with colorectal cancer . The care pathways for cancer patients are particularly well defined by the various national plans. The pharmacist plays a central role at different levels. Within the framework of colorectal cancer prevention, they now participate in the distribution of screening tests. For several years, the public health missions of pharmacists have been evolving in the interest of patients, in compliance with legislative and regulatory texts, but also with the recommendations of authorities and learned societies. (c) 2023 Elsevier Masson SAS. All rights reserved
引用
收藏
页码:33 / 36
页数:4
相关论文
共 9 条
  • [1] Haute Autorite de sante, 2014, ANN ACC DIAGN PAT AY
  • [2] Haute Autorite de sante, 2017, CANC COL MOD DEP PRE
  • [3] L'Assurance maladie, 2022, BIL PART MED ACC PHA
  • [4] L'Assurance maladie, 2022, ACC PHARM PAT ANT VO
  • [5] L'Assurance maladie, BIL PART MED ACC PHA
  • [6] Legifrance, ART D6124 131 COD SA
  • [7] Legifrance, ART R4235 48 COD SAN
  • [8] Legifrance, ART L1111 23 COD SAN
  • [9] Republique francaise Institut national du cancer, ASS MAL PROGR NAT DE